Annual low‑dose CT scans cut lung‑cancer deaths by 20% for smokers aged 50‑80, but many eligible people skip the test, leading to preventable fatalities.
Posts tagged as “lung cancer”
A small study of the RAS‑targeting drug daraxonrasib reported tumor shrinkage in over 30% of patients with KRAS‑mutated non‑small‑cell lung cancer.